Testing Before Treating: Molecular Determinants of Optimal Therapy for NSCLC

Learn how experts test for biomarkers in patients with NSCLC with multidisciplinary perspectives from a medical oncologist and a pathologist toward the optimal care of patients with NSCLC including a downloadable slideset from the live webinar a focused text-based module and expert-authored commentaries on optimal biomarker testing to guide treatment for patients with NSCLC.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bayer Healthcare Pharma

Daiichi Sankyo, Inc.

Genentech TEXT Only

Janssen administered by Scientific Affairs

Lilly

Novartis Pharmaceuticals Corporation

Partners

AMP

ProCE Banner